|
Skybiotech Healthcare Ltd.
|
HALFYEARLY RESULTS
|
|
|
You can view the
Halfyearly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
25.69 Cr.
|
P/BV
|
2.94
|
Book Value (Rs.)
|
45.55
|
|
52 Week High/Low (Rs.)
|
239/127
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 4.30 | 3.54 | 3.51 |
| Total Income From Operations | 4.30 | 3.54 | 3.51 |
| | | | |
| EXPENDITURE | | | |
| Consumption of Raw Materials | 1.58 | 1.77 | 1.91 |
| Increase/Decrease in Stocks | 0.44 | 0.34 | -0.39 |
| Employees Cost | 0.96 | 1.07 | 0.89 |
| Depreciation | 0.24 | 0.29 | 0.25 |
| Other Expenses | 1.47 | 1.76 | 1.97 |
| Total Expenses | 4.70 | 5.23 | 4.62 |
| | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -0.39 | -1.69 | -1.11 |
| Other Income | 0.07 | -0.04 | 0.42 |
| P/L Before Interest, Excpt. Items & Tax | -0.32 | -1.72 | -0.69 |
| Interest | 0.01 | -0.13 | 0.14 |
| P/L Before Exceptional Items & Tax | -0.33 | -1.60 | -0.83 |
| P/L Before Tax | -0.33 | -1.60 | -0.83 |
| Tax | 0.00 | -0.12 | 0.06 |
| P/L After Tax from Ordinary Activities | -0.33 | -1.48 | -0.89 |
| Net Profit/Loss For the Period | -0.33 | -1.48 | -0.89 |
| Net P/L After Minority Interest & Share Of Associates | -0.33 | -1.48 | -0.89 |
| | | | |
| Equity Share Capital | 1.92 | 1.92 | 1.92 |
| EPS Before Extra Ordinary * | | | |
| Basic EPS (Rs.) | -1.38 | -7.72 | -2.56 |
| Diluted EPS (Rs.) | -1.38 | (7.71) | -2.56 |
| EPS After Extra Ordinary * | | | |
| Basic EPS (Rs.) | -1.38 | -7.72 | -2.56 |
| Diluted EPS (Rs.) | -1.38 | (7.71) | -2.56 |
| | | | |
| PBITOE Margin (%) | -9.08 | -47.67 | -31.57 |
| PBTE Margin (%) | -7.62 | -45.17 | -23.54 |
| PBT Margin (%) | -7.62 | -45.17 | -23.54 |
| PAT Margin (%) | -7.62 | -41.75 | -25.39 |
| PAT After MI And SOA Margin (%) | -7.62 | -41.75 | -25.39 |
